Merck (MRK) FCF Payout Ratio (2009 - 2026)

Merck has disclosed FCF Payout Ratio across 18 years of filings, most recently posting 0.72 for Q1 2026.

• In Q1 2026, FCF Payout Ratio fell 58.88% year-over-year to 0.72; the TTM figure through Mar 2026 stood at 0.58 (up 25.14% YoY), while the FY2025 annual figure was 0.66, up 52.68% from the prior year.
• FCF Payout Ratio fell to 0.72 in Q1 2026, from 1.11 in the prior quarter.
• Over the last five years, FCF Payout Ratio for MRK reached as high as 5.58 in Q1 2023 and fell as low as 2.49 in Q4 2023.
• The 5-year median for FCF Payout Ratio is 0.56 (2022), against an average of 0.76.
• The widest YoY moves for FCF Payout Ratio: up 1108.06% in 2023, down 567.33% in 2023.
• A 5-year view of FCF Payout Ratio shows it stood at 0.53 in 2022, then plunged by 567.33% to 2.49 in 2023, then soared by 131.15% to 0.78 in 2024, then soared by 42.51% to 1.11 in 2025, then slumped by 35.0% to 0.72 in 2026.
• According to Business Quant data, FCF Payout Ratio over the past three periods registered 0.72, 1.11, and 0.3 for Q1 2026, Q4 2025, and Q3 2025 respectively.